Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CL Stock Forecast 2025-2026
$87.57
Current Price
$70.97B
Market Cap
Buy 13
Hold 7
Sell 2
Wall St Analyst Ratings
Distance to CL Price Targets
+25.6%
To High Target of $110.00
+14.2%
To Median Target of $100.00
-4.1%
To Low Target of $84.00
CL Price Momentum
-2.5%
1 Week Change
-6.3%
1 Month Change
-7.4%
1 Year Change
-3.7%
Year-to-Date Change
-19.9%
From 52W High of $109.30
+2.6%
From 52W Low of $85.32
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Colgate (CL) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on CL and similar high-potential opportunities.
Latest CL Stock Price Targets & Analyst Predictions
Based on our analysis of 28 Wall Street analysts, CL has a bullish consensus with a median price target of $100.00 (ranging from $84.00 to $110.00). The overall analyst rating is Buy (7.5/10). Currently trading at $87.57, the median forecast implies a 14.2% upside. This outlook is supported by 13 Buy, 7 Hold, and 2 Sell ratings.
The most optimistic forecast comes from Robert Moskow at TD Cowen, projecting a 25.6% upside. Conversely, the most conservative target is provided by Lauren Lieberman at Barclays, suggesting a 4.1% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CL Analyst Ratings
13
Buy
7
Hold
2
Sell
CL Price Target Range
Low
$84.00
Average
$100.00
High
$110.00
Current: $87.57
Latest CL Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CL.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 28, 2025 | JP Morgan | Andrea Teixeira | Overweight | Maintains | $103.00 |
| Apr 28, 2025 | Citigroup | Filippo Falorni | Buy | Maintains | $108.00 |
| Apr 17, 2025 | UBS | Peter Grom | Buy | Maintains | $109.00 |
| Apr 11, 2025 | JP Morgan | Andrea Teixeira | Overweight | Maintains | $95.00 |
| Apr 11, 2025 | Barclays | Lauren Lieberman | Equal-Weight | Maintains | $86.00 |
| Apr 2, 2025 | Wells Fargo | Chris Carey | Underweight | Maintains | $88.00 |
| Mar 31, 2025 | Piper Sandler | Korinne Wolfmeyer | Overweight | Maintains | $107.00 |
| Mar 27, 2025 | Barclays | Lauren Lieberman | Equal-Weight | Maintains | $89.00 |
| Mar 14, 2025 | JP Morgan | Andrea Teixeira | Overweight | Maintains | $99.00 |
| Feb 3, 2025 | Raymond James | Olivia Tong | Outperform | Reiterates | $105.00 |
| Feb 3, 2025 | Morgan Stanley | Dara Mohsenian | Overweight | Maintains | $104.00 |
| Feb 3, 2025 | Stifel | Mark Astrachan | Hold | Maintains | $93.00 |
| Feb 3, 2025 | UBS | Peter Grom | Buy | Maintains | $100.00 |
| Feb 3, 2025 | RBC Capital | Nik Modi | Sector Perform | Maintains | $98.00 |
| Feb 3, 2025 | JP Morgan | Andrea Teixeira | Overweight | Maintains | $97.00 |
| Jan 29, 2025 | RBC Capital | Nik Modi | Sector Perform | Reiterates | $101.00 |
| Jan 17, 2025 | Barclays | Lauren Lieberman | Equal-Weight | Maintains | $83.00 |
| Jan 17, 2025 | Stifel | Mark Astrachan | Hold | Maintains | $95.00 |
| Jan 16, 2025 | UBS | Peter Grom | Buy | Maintains | $104.00 |
| Jan 16, 2025 | JP Morgan | Andrea Teixeira | Overweight | Maintains | $103.00 |
Colgate-Palmolive Co. (CL) Competitors
The following stocks are similar to Colgate based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Colgate-Palmolive Co. (CL) Financial Data
Colgate-Palmolive Co. has a market capitalization of $70.97B with a P/E ratio of 24.8x. The company generates $19.95B in trailing twelve-month revenue with a 14.5% profit margin.
Revenue growth is -3.0% quarter-over-quarter, while maintaining an operating margin of +21.8% and return on equity of +451.3%.
Valuation Metrics
Market Cap
$70.97B
Enterprise Value
$78.30B
P/E Ratio
24.8x
PEG Ratio
22.7x
Price/Sales
3.6x
Growth & Margins
Revenue Growth (YoY)
-3.0%
Gross Margin
+60.8%
Operating Margin
+21.8%
Net Margin
+14.5%
EPS Growth
+1.0%
Financial Health
Cash/Price Ratio
+1.8%
Current Ratio
0.8x
Debt/Equity
1,128.1x
ROE
+451.3%
ROA
+16.0%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Colgate-Palmolive Co. (CL) Business Model
About Colgate-Palmolive Co.
What They Do
Global consumer products company for personal care.
Business Model
Colgate-Palmolive generates revenue through the sale of a diverse range of products in oral care, personal care, home care, and pet nutrition. Its extensive distribution network includes supermarkets, drug stores, and e-commerce platforms, allowing it to reach consumers in over 200 countries.
Additional Information
Founded in 1806 and based in New York City, Colgate-Palmolive is a key player in the consumer staples sector, offering products that are essential for daily personal and household routines. The company's strong brand recognition and extensive product line contribute to its market stability and influence.
Company Information
Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
34,000
CEO
Mr. Noel R. Wallace
Country
United States
IPO Year
1977
Website
www.colgatepalmolive.comColgate-Palmolive Co. (CL) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Colgate Stock Slips 7% in a Month: What's the Best Move Now?
With CL's stock declining and valuation stretched, is it time for caution, booking profits or rethinking your approach?
May 14, 2025
By Zacks Equity Research
Analyst Blog
GO vs. CL: Which Stock Should Value Investors Buy Now?
GO vs. CL: Which Stock Is the Better Value Option?
May 13, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
CL shows strong performance due to effective pricing and productivity measures, supported by a promising innovation strategy.
Why It Matters
CL's strong pricing power and productivity gains signal potential revenue growth, while its innovation strategy suggests future competitive advantages, positively influencing investor sentiment.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Colgate-Palmolive executives will participate in a fireside chat at the Goldman Sachs Global Staples Forum on May 13, 2025. A live webcast will be available on their website.
Why It Matters
Colgate-Palmolive executives discussing strategies at a major investor forum could signal insights into future performance and market positioning, influencing stock valuations and investor sentiment.
Source: Business Wire
Market Sentiment:
Neutral
Best Dividend Aristocrats For May 2025
16 days ago
Quick Summary
In April, Dividend Aristocrats are underperforming the S&P 500, with NOBL down 4.88%. Year-to-date, top performers include Consolidated Edison (+25.65%) and Coca-Cola (+16.18%). 33 Aristocrats announced 2025 dividend increases averaging 4.33%.
Why It Matters
Underperformance of Dividend Aristocrats relative to the S&P 500 may signal shifting market dynamics. However, consistent dividend increases and top performers indicate potential long-term value.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Consumer trends, digital growth, cost reductions, and tariff issues are influencing investment decisions between Procter & Gamble (PG) and Colgate-Palmolive (CL).
Why It Matters
Shifting consumer trends and digital strategies impact competitive positioning. Cost cuts and tariffs affect profitability, influencing stock performance of PG and CL. Analyze for better investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Colgate-Palmolive Co (CL) reported first-quarter FY25 earnings that exceeded expectations.
Why It Matters
Better-than-expected earnings from Colgate-Palmolive may indicate strong demand and effective cost management, potentially boosting investor confidence and stock performance.
Source: Benzinga
Market Sentiment:
Positive
Colgate-Palmolive Webcasts 2025 Annual Meeting of Stockholders May 9, 2025 – 10:00 a.m. ET
17 days ago
Quick Summary
Colgate-Palmolive will host its 2025 Annual Meeting of Stockholders via live webcast on May 9, 2025, at 10:00 a.m. ET. Access begins at 9:30 a.m. ET, with a recorded version available later.
Why It Matters
Colgate-Palmolive's annual meeting webcast offers transparency, enabling investors to hear directly from management about company strategy and performance, which can influence stock valuation.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About CL Stock
What is Colgate-Palmolive Co.'s (CL) stock forecast for 2025?
Based on our analysis of 28 Wall Street analysts, Colgate-Palmolive Co. (CL) has a median price target of $100.00. The highest price target is $110.00 and the lowest is $84.00.
Is CL stock a good investment in 2025?
According to current analyst ratings, CL has 13 Buy ratings, 7 Hold ratings, and 2 Sell ratings. The stock is currently trading at $87.57. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CL stock?
Wall Street analysts predict CL stock could reach $100.00 in the next 12 months. This represents a 14.2% increase from the current price of $87.57. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Colgate-Palmolive Co.'s business model?
Colgate-Palmolive generates revenue through the sale of a diverse range of products in oral care, personal care, home care, and pet nutrition. Its extensive distribution network includes supermarkets, drug stores, and e-commerce platforms, allowing it to reach consumers in over 200 countries.
What is the highest forecasted price for CL Colgate-Palmolive Co.?
The highest price target for CL is $110.00 from Robert Moskow at TD Cowen, which represents a 25.6% increase from the current price of $87.57.
What is the lowest forecasted price for CL Colgate-Palmolive Co.?
The lowest price target for CL is $84.00 from Lauren Lieberman at Barclays, which represents a -4.1% decrease from the current price of $87.57.
What is the overall CL consensus from analysts for Colgate-Palmolive Co.?
The overall analyst consensus for CL is bullish. Out of 28 Wall Street analysts, 13 rate it as Buy, 7 as Hold, and 2 as Sell, with a median price target of $100.00.
How accurate are CL stock price projections?
Stock price projections, including those for Colgate-Palmolive Co., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 15, 2025 9:31 PM UTC